Anacura

Translating your analytical tests to the GMP level to accelerate filing submission for clinical trials

26/06/2017
35360921616_de854468f7_k

At the event “Towards the Future: Synergizing Efforts for the Next Generation of Cell Therapeutics” in Niel on 13th of June”, Griet Nuytinck (CEO Anacura) and Nathalie Van Bruaene (Head cell-based division Anacura LS) presented how Anacura is part of the value chain in cell therapy development during their talk:

Translating your analytical tests to the GMP level to accelerate filing submission for clinical trials

  • Development of new ATMP’s is challenging, often combined with multiple obstacles and huge time pressure
  • To save time & extra resources the cell-based team of Anacura can help to accelerate by translating & validating your analytical tests. This was shown by several practical examples

 

Interested in our services for your cell therapy development journey? Contact us and we are happy to help you! 

We will keep you posted about our news and events.

Need a customized solution or more information about a service?